Skip to main content
SpringerLink
Log in

Vergleich oder Kombination von ß-BIockern und Kalziumantagonisten bei stabiler und instabiler Angina pectoris

  • Chapter
Betablocker — im Mittelpunkt der Forschung

  • 27 Accesses

Zusammenfassung

Der vorliegende Beitrag gibt einen Überblick zum Thema Vergleich oder Kombination von β-Blockern und Kalziumantagonisten bei stabiler und instabiler Angina pectoris. Diskutiert werden Fragen wie Symptomatik, Belastungstoleranz, Ischämie unter Alltagsbelastung, Morbidität und Mortalität.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Selwyn AP, Yeung AC, Ryan TJ, Raby K, Barry J, Ganz P (1992) Pathophysiology of ischemia in patients with coronary artery disease. Prog Cardiovasc Dis 35: 27–39.

    Article  PubMed  CAS  Google Scholar 

  2. Pepine CJ (1993) Betablockers or calcium antagonists in silent ischemia? Eur Heart J 14: F7–F14.

    Google Scholar 

  3. Portegies MCM, Gilst WH van, Lie KI. (1994) Treatment of myocardial ischemia with calcium antagonists High blood pressure 3 (Suppl. 1) 1–12.

    Google Scholar 

  4. Picca M, Azzollini F, Cereda A, Pelosi G (1989) Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris. Eur J Clin Pharmacol 37: 325–331.

    Article  PubMed  CAS  Google Scholar 

  5. Opie LH (1994) Angina pectoris and calcium antagonists. In: LH Opie (ed) Myocardial pro-tection by calcium antagonists. Wiley-Liss, New York, pp 62–69.

    Google Scholar 

  6. Van Dijk RB, Lie KI, Crijns HJGM (1988) Diltiazem in comparison with metoprolol in stable angina pectoris. Eur Heart J 9: 1194–1199.

    PubMed  Google Scholar 

  7. Findlay IN, MacLeod K, Gillen G et al. (1987) A double-blind placebo-controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris. Br Heart J 57: 336–343.

    Article  PubMed  CAS  Google Scholar 

  8. Shapiro W, Narahara KA, Kostis JB et al. (1989) Comparison of atenolol and nifedipine in chronic stable angina pectoris. Am J Cardiol 64: 186–190.

    Article  PubMed  CAS  Google Scholar 

  9. Borzak S, Fenton R, Glasser S et al. for the Angina and Silent Ischemia Study Group (ASIS) (1993) Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. J Am Coll Cardiol 21: 1605–1611.

    Article  Google Scholar 

  10. Kostuk WJ, Pflugfelder O (1987) Comparative effects of calcium-entry blocking drugs, beta- blocking drugs, and their combination in patients with chronic stable angina. Circulation 75: V114–V121.

    PubMed  CAS  Google Scholar 

  11. Brouwer J, Viersma JW, Van Veldhuisen DJ et al. (1995) Usefulness of heart rate variability in predicting drug efficacy (metoprolol vs. diltiazem) in patients with stable angina pectoris. Am J Cardiol 76: 759–763.

    Article  PubMed  CAS  Google Scholar 

  12. Portegies MCM, Sijbring P, Gobel EJAM, Viersma JW, Lie KI (1994) Efficacy of metoprolol and diltiazem in treating silent myocardial ischemia. Am J Cardiol 74: 1095–1098.

    Article  PubMed  CAS  Google Scholar 

  13. Arnim T von for the TIBBS Investigators (1995) Medical treatment to reduce total ischemic burden: Total Ischemic Burden Bisoprolol Study (TIBBS), a multicenter trial comparing biso- prolol and nifedipine. J Am Coll Cardiol 25: 231–238.

    Article  Google Scholar 

  14. Mulcahy D, Cunningham D, Crean P et al. (1988) Circadian variation of total ischemic burden and its alteration with anti-anginal agents. Lancet ii: 755–759.

    Article  Google Scholar 

  15. Theroux P, Baird M, Juneau M et al. (1991) Effect of diltiazem on symptomatic and asymptomatic episodes of ST segment depression occurring during daily life and during exercise. Circulation 84: 15–22.

    PubMed  CAS  Google Scholar 

  16. Parmley WW, Nesto RW, Singh BN, Deanfield J, Gottlieb SO (1992) Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. J Am Coll Cardiol 19: 1380–1389.

    Article  PubMed  CAS  Google Scholar 

  17. Rocco MB, Nabel EG, Campbell S, Goldman L (1988) Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with coronary disease. Circulation 78: 877–884.

    Article  PubMed  CAS  Google Scholar 

  18. Deedwania PC, Carbajal EV (1990) Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 81: 748–756.

    Article  PubMed  CAS  Google Scholar 

  19. Pepine CJ, Cohn PF, Deedwania PC et al. (1994) Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 90: 762–768.

    PubMed  CAS  Google Scholar 

  20. Dargie HJ, Fox KM (1996) Total Ischemic Burden European Trial (TIBET). Effects of ischemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. Eur Heart J 17: 104–112.

    PubMed  CAS  Google Scholar 

  21. Rehnqvist N, Hjemdahl P, Billing E et al. (1996) Effects of metoprolol vs. verapamil in patients with stable angina pectoris. The angina Prognosis Study in Stockholm (APSIS). Eur Heart J 17: 76–81.

    PubMed  CAS  Google Scholar 

  22. Rogers W, Bourassa MG, Andrews TC et al. (1995) Asymptomatic Cardiac Ischemia Pilot (ACIP) Study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol 26: 594–605.

    Article  PubMed  CAS  Google Scholar 

  23. Kostuk WJ, Pflugfelder P (1987) Comparative effects of calcium entry-blocking drugs, beta- blocking drugs, and their combination in patients with chronic stable angina. Circulation 75(suppl V): V-114–V-121.

    CAS  Google Scholar 

  24. El-Tamimi, Davies GJ, Kaski J-C et al. (1989) Effects of diltiazem alone or with isosorbidedi- nitrate or with atenolol both acutely and chronically for stable angina pectoris. Am J Cardiol 64: 717–724.

    Article  PubMed  CAS  Google Scholar 

  25. Dargie HJ, Kynch PG, Krikler DM, Harrsi L, Krikler S (1981) Nifedipine and propranolol: a beneficial drug interaction. Am J Med 71: 676–682.

    Article  PubMed  CAS  Google Scholar 

  26. Hill JA, Gonzalez JI, Kolb R, Pepine CJ (1991) Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia. Am J Cardiol 67: 671–675.

    Article  PubMed  CAS  Google Scholar 

  27. Egstrup K (1988) Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina: effects on total ischemic activity and heart rate at onset of ischemia. Am Heart J 116: 971–978.

    Article  PubMed  CAS  Google Scholar 

  28. Savonitto S, Ardissino D, Egstrup K et al. (1996) Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the Interna-tional Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol 27: 311–316.

    Article  PubMed  CAS  Google Scholar 

  29. Akhras F, Jackson G (1991) Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina pectoris. Lancet 338: 1036–1039.

    Article  PubMed  CAS  Google Scholar 

  30. Dunselman PHJM, Liem AH for the Working Group on Cardiovascular Research the Netherlands (1996) Felodipine, metoprolol and their combination for the treatment of stable angina pectoris. Cardiology 3: 206.

    Google Scholar 

  31. Vries RJ de, Dunselman PHJM, Veldhuisen DJ van, Heuvel AF van den, Wielenga RP, Lie KI (1994) Comparison between felodipine. and isosorbide mononitrate as adjunct to beta- blockade in patients >65 years of age with angina pectoris. Am J Cardiol 74: 1201–1206.

    Article  PubMed  Google Scholar 

  32. Egstrup K, Andersen, PE (1993) Transient myocardial ischemia during nifedipine therapy in stable angina pectoris and its relation to coronary collateral flow. Am J Cardiol 71: 177–183.

    Article  PubMed  CAS  Google Scholar 

  33. Maseri A (1995) Regulation of coronary vasomotore tone. In: Maseri A (ed) Ischemic heart disease. Churchill, Livingstone, New York p 9–105, chapter 5.

    Google Scholar 

  34. Report of the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. (1986) Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both. Br Heart J 56: 400–413.

    Article  Google Scholar 

  35. Muller JE, Morrison J, Stone P et al. (1984) Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized double blind placebo controlled comparison. Circulation 69: 740–747.

    Article  PubMed  CAS  Google Scholar 

  36. Gobel EJAM, Hautvast RWM, Gilst WH van et al. (1995) Randomized double-blind trial of diltiazem versus glyceryl trinitrate for unstable angina pectoris. Lancet 346: 1653–1657.

    Article  PubMed  CAS  Google Scholar 

  37. Gerstenblith G, Ouyang P, Aschuff SC et al. Nifedipine in unstable angina. A double-blind randomised trial. N Engl J Med 306: 885–889.

    Google Scholar 

  38. Muller JE, Turi ZG, Pearle DL et al. (1984) Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. Circulation 69: 728–739.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. C. M. Portegies
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. I. Lie
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pharmakologie, Med. Universität zu Lübeck, Ratzeburger Allee 160, D-23538, Lübeck, Germany

    P. Dominiak

  2. Division of Cardiology, Sahlgrenska University Hospital, S-413345, Göteborg, Germany

    A. Hjalmarson

  3. Clinical Pharmacology Section, University of Birmingham, Edgbaston, Brimingham B15 2TH, Edgbaston, UK

    M. J. Kendall

  4. Innere Medizin III, Universität Heidelberg, Bergheimer Str. 58, D-69115, Heidelberg, Germany

    W. Kübler

  5. Astra Hässle AB, Clinical R&D, S-43183, Mölndal, Sweden

    G. Olsson

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Portegies, M.C.M., Lie, K.I. (1997). Vergleich oder Kombination von ß-BIockern und Kalziumantagonisten bei stabiler und instabiler Angina pectoris. In: Dominiak, P., Hjalmarson, A., Kendall, M.J., Kübler, W., Olsson, G. (eds) Betablocker — im Mittelpunkt der Forschung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60716-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60716-5_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64522-8

  • Online ISBN: 978-3-642-60716-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation